Stocktoria
BioNexus Gene Lab Corp BGLC
BioNexus Gene Lab Corp financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $9.5M | $9.8M | $10.9M | $13.4M | $11.4M | $126,955 | $212,328 |
| Gross profit | $1.1M | $1.3M | $1.3M | $1.3M | $2.3M | $1.7M | $55,888 | $28,765 |
| R&D expense | $50,670 | $47,511 | $54,982 | — | — | — | — | — |
| Operating income | -$3.0M | -$1.6M | -$2.6M | -$291,177 | $1.1M | $1.3M | -$275,705 | $59,901 |
| Interest expense | — | — | $13,929 | $12,479 | — | — | — | — |
| Income tax | $0 | -$3,494 | -$21,526 | -$52,310 | -$291,283 | — | $24,759 | -$33,447 |
| Net income | -$3.0M | -$1.6M | -$2.6M | -$355,966 | $751,571 | $1.1M | -$246,469 | $26,454 |
| EPS (diluted) | — | $-0.09 | $-0.17 | — | — | — | — | — |
| Operating cash flow | -$1.8M | -$2.1M | -$1.8M | $551,822 | $9,161 | $552,680 | -$217,273 | -$274,080 |
| Free cash flow | -$1.9M | -$2.3M | -$2.0M | $551,822 | $5,999 | $131,059 | -$230,090 | -$234,459 |
| Cash & equivalents | $2.5M | $2.9M | — | — | $2.1M | $2.8M | $859,076 | $1.3M |
| Inventory | $676,703 | $1.4M | $1.1M | $977,807 | $1.5M | $1.2M | $7,580 | $15,301 |
| Total assets | $9.3M | $10.4M | $11.4M | $8.7M | $9.6M | $10.1M | $1.2M | $1.7M |
| Total liabilities | $637,856 | $2.1M | $1.7M | $2.1M | $2.4M | $3.5M | $108,872 | $130,313 |
| Shareholders' equity | $8.6M | $8.3M | $9.7M | $6.7M | $7.2M | $6.7M | $1.1M | $1.5M |
Growth · year-over-year · Revenue CAGR 66.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | -21.9% | -2.7% | -10.6% | -18.2% | +17.3% | +8872.0% | -40.2% | — |
| Net income growth | — | — | — | -147.4% | -31.3% | — | -1031.7% | — |
| Free cash flow growth | — | — | -457.3% | +9098.6% | -95.4% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.